Skip to content

The Role of Fat Emboli in the Trauma Inflammatory Response

The Role of Fat Emboli in the Trauma Inflammatory Response

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02069327
Enrollment
9
Registered
2014-02-24
Start date
2012-11-30
Completion date
2014-11-30
Last updated
2019-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Fracture

Keywords

Femur, Fat, Emboli, Bone, Marrow, proteomic, proteomics, metabolomics, metabolomic, inflammatory, cytokine, chemokine, anaphlylatoxin, Thromboelastography, Medical Center of the Rockies, Fat Embolism Syndrome, Injury, Fracture, Metabolite, MCR, TEG, FES

Brief summary

This is an observational study designed to investigate the role of fat emboli in patients who are undergoing a tibial or femoral fracture procedure in the operating room. The purpose of this study is to obtain samples of bone marrow and blood during tibial or femoral fracture procedures to understand the inflammatory response.

Detailed description

Bone marrow is routinely removed during a tibial or femoral fracture procedure; researchers will take samples for this study from bone marrow that has already been removed as part of this procedure. No additional marrow samples will be taken as part of this research study. Also, researchers will collect blood (about 4 teaspoons) for testing inflammatory response and coagulation. Researchers may need to insert an additional line to collect your blood.

Interventions

None listed

Sponsors

Colorado State University
CollaboratorOTHER
Poudre Valley Health System
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing a tibial or femoral fracture procedure in the operating room.

Exclusion criteria

* n/a

Design outcomes

Primary

MeasureTime frameDescription
Inflammatory ResponseOne daySamples will be tested using proteomic and metabolomic assays from samples of bone marrow reamed during intramedullary (IM) femoral nailing. Blood samples drawn at the time of IM nailing will be tested to determine if clinically relevant amounts of marrow containing these inflammatory mediators are released into the bloodstream.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026